Therapeutic options and outcomes for the treatment of neonates and preterms with gram-negative multidrug-resistant bacteria: a systematic review

HIGHLIGHTS

  • who: Lorenzo Chiusaroli et al. from the Division of Pediatric Infectious Diseases, Department for Women's and Child's Health, University of Padua, Padua, Italy have published the article: Therapeutic Options and Outcomes for the Treatment of Neonates and Preterms with Gram-Negative Multidrug-Resistant Bacteria: A Systematic Review, in the Journal: Antibiotics 2022, 1088 of /2022/
  • what: The authors focused the research on four MDROs: Enterobacterales producing extended-spectrum beta-lactamase (ESBL) or carbapenemase (CRE) Pseudomonas and Acinetobacter PROSPERO registration: CRD42022346739 Results: This systematic review was carried out according to the Preferred Reporting Items . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?